Over-the-counter and natural remedies for onychomycosis: do they really work?
- PMID: 28040821
Over-the-counter and natural remedies for onychomycosis: do they really work?
Abstract
Onychomycosis is a fungal infection of the nail unit that may lead to dystrophy and disfigurement over time. It accounts for up to 50% of all nail conditions, with toenails affected more commonly than fingernails. Onychomycosis may affect quality of life and increase the prevalence and severity of foot ulcers in patients with diabetes. Available oral agents approved by the US Food and Drug Administration (FDA) for the treatment of onychomycosis include terbinafine and itraconazole, which have demonstrated good efficacy but are associated with the risk of systemic side effects and drug-drug interactions. Topical medications that are FDA approved for onychomycosis include ciclopirox, efinaconazole, and tavaborole. These therapies generally have incomplete efficacy compared to systemic agents as well as long treatment courses and possible local side effects such as erythema and/or blisters. Given the need for safe, effective, and cost-effective options for onychomycosis therapy, there has been a renewed interest in natural and over-the-counter (OTC) alternatives. This review will synthesize the laboratory data, known antifungal mechanisms, and clinical studies assessing the efficacy of OTC and natural products for onychomycosis treatment.
Similar articles
-
Efinaconazole and Tavaborole.J Pharm Pract. 2017 Apr;30(2):245-255. doi: 10.1177/0897190016630904. Epub 2016 Jul 8. J Pharm Pract. 2017. PMID: 26873506 Review.
-
Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration.Arch Dermatol Res. 2020 Oct;312(8):581-586. doi: 10.1007/s00403-020-02044-7. Epub 2020 Feb 19. Arch Dermatol Res. 2020. PMID: 32076805
-
Antifungal agents for onychomycosis: new treatment strategies to improve safety.Dermatol Online J. 2016 Mar 16;22(3):13030/qt8dg124gs. Dermatol Online J. 2016. PMID: 27136621 Review.
-
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.Semin Cutan Med Surg. 2016 Mar;35(3 Suppl 3):S51-5. doi: 10.12788/j.sder.2016.009. Semin Cutan Med Surg. 2016. PMID: 27074700
-
Tavaborole - a treatment for onychomycosis of the toenails.Expert Rev Clin Pharmacol. 2016 Sep;9(9):1145-52. doi: 10.1080/17512433.2016.1206467. Epub 2016 Jul 14. Expert Rev Clin Pharmacol. 2016. PMID: 27347905 Review.
Cited by
-
Synergistic potential of essential oil combinations against Microsporum, Trichophyton, and Epidermophyton.Int Microbiol. 2024 Aug 26. doi: 10.1007/s10123-024-00566-y. Online ahead of print. Int Microbiol. 2024. PMID: 39186133
-
Truth or Trend - Misinformation Spreading Fast on TikTok: A Cross-Sectional Analysis of Onychomycosis Content.Skin Appendage Disord. 2023 Dec;9(6):444-448. doi: 10.1159/000533319. Epub 2023 Sep 1. Skin Appendage Disord. 2023. PMID: 38058543
-
Case of Mixed Infection of Toenail Caused by Candida parapsilosis and Exophiala dermatitidis and In Vitro Effectiveness of Propolis Extract on Mixed Biofilm.J Fungi (Basel). 2023 May 17;9(5):581. doi: 10.3390/jof9050581. J Fungi (Basel). 2023. PMID: 37233292 Free PMC article.
-
High Frequency of Self-Diagnosis and Self-Treatment in a Nationally Representative Survey about Superficial Fungal Infections in Adults-United States, 2022.J Fungi (Basel). 2022 Dec 22;9(1):19. doi: 10.3390/jof9010019. J Fungi (Basel). 2022. PMID: 36675840 Free PMC article.
-
Updated Perspectives on the Diagnosis and Management of Onychomycosis.Clin Cosmet Investig Dermatol. 2022 Sep 15;15:1933-1957. doi: 10.2147/CCID.S362635. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36133401 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical